· 禮來IL-13抗體“LEBRIKIZUMAB”獲FDA批準上... | 2024-09-19 16:57:31 |
· 禮來lebrikizumab再獲關鍵3期臨床積極結果 | 2021-12-22 14:59:21 |
· 禮來濕疹抗體療法lebrikizumab達到3期臨床終點 | 2021-08-17 15:16:19 |
· Lebrikizumab一項哮喘2期試驗獲肯定結果 | 2011-08-08 07:18:29 |
· Lebrikizumab哮喘一項2期試驗獲肯定結果 | 2011-08-08 12:31:33 |
| |||||||